See today's BioWorld Science
To read the full story, subscribe or sign in.
Musculoskeletal

Epirium’s MF-300 cleared to enter clinic for sarcopenia

Dec. 24, 2024
Epirium Bio Inc. has obtained IND clearance from the FDA for MF-300, a first-in-class orally administered, 15-hydroxyprostaglandin dehydrogenase (15-PGDH) enzyme inhibitor.
BioWorld Science Regulatory Musculoskeletal Small molecule FDA IND